Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Program
        • PEP++ project
        • PEP4LEP 2.0 & PEP4LEP
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • Prevention of Leprosy (SDR-PEP) Toolkit
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Leprosy: Why does it persist among us?

Santos V, de Souza C, Martins-Filho P, et al. Expert review of anti-infective therapy. 2020;
Publication

Biotechnological and Immunological Platforms Based on PGL-I Carbohydrate-Like Peptide of Mycobacterium leprae for Antibodies Detection Among Leprosy Clinical Forms.

Lima M, Capparelli FE, Oliveira J, et al. Frontiers in microbiology. 2020;
Download PDF
Publication

Breve historico da hanseníase: Diagnóstico e tratamento

da Silva K, de Oliveira E, Morais F, et al. Atena Editora. Ações de Saúde e Geração de Conhecimento nas Ciências Médicas 3. 2020;
Download PDF
Publication

Delay in leprosy diagnosis

Marfatia Y, Surani A, Shah D. Indian journal of leprosy. 2020; 92 (1) : 19-29.
Download PDF
Publication

Leprosy: Clinical Aspects and Diagnostic Techniques.

Maymone M, Laughter M, Venkatesh S, et al. Journal of the American Academy of Dermatology. 2020;
Publication

Delayed diagnosis in leprosy

Camacho I, Burdick A. Journal of investigative dermatology. 2007;
Download PDF
Publication

Leprosy reactions: Earlier diagnosis leads to more effective treatment.

Thangaraju P, Venkatesan S. Revista da Sociedade Brasileira de Medicina Tropical. 2020;
Download PDF
Publication

Development of LepReact, a defined skin test for paucibacillary leprosy and low-level M. leprae infection.

Duthie M, Pena MT, Khandhar AP, et al. Applied microbiology and biotechnology. 2020;
Publication

Diagnóstico de lepra en una comunidad ecuatoriana

Suárez J, Sánchez D, Moreira O. Revista Cubana de medicina general integral. 2020;
Download PDF
Publication

Fluorescent hybridization of in skin samples collected in Burkina Faso.

Millogo A, Loukil A, Fellag M, et al. Journal of clinical microbiology. 2020;

Pagination

  • Previous page ‹‹
  • Page 99
  • Next page ››
Subscribe to Diagnosis

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD